,26 To test the efficacy of NCB-0846 during prostate cancer treatment and in CRPC, we initially assessed the efficacy of NCB-0846 in suppressing TNIK protein expression in C4-2 and PC3 cells. The gene discussed is TNIK; the disease is prostate cancer.